SAN FRANCISCO, Oct 21 (Xinhua): US scientists at University of California, San Francisco (UCSF) have developed a new drug that can restore the function of oxygen-starved heart tissue under the conditions of hypoxia, according to the results of a new study released over the weekend.
The new drug called OMX-CV was developed by Omniox, Inc., one of the first biotech startups launched in the incubator space on the UCSF's Mission Bay campus in 2010.
The biopharmaceutical company has been developing oxygen-delivery therapeutics for the treatment of cancer, cardiovascular diseases, trauma and other conditions in which low oxygen levels, or hypoxia, negatively impact disease outcomes.
The new drug does not cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. It delivers its precious oxygen cargo only to the tissues that need it most.
Scientists create drug to run oxygen-starved hearts
FE Team | Published: October 22, 2018 00:14:39
Scientists create drug to run oxygen-starved hearts
Share if you like